Skip to main content

Table 1 Assay validation on cfDNA and paternal samples

From: Targeted capture enrichment followed by NGS: development and validation of a single comprehensive NIPT for chromosomal aneuploidies, microdeletion syndromes and monogenic diseases

DescriptioncfDNA and biological father DNAConfirmed invasive prenatal diagnosisConfirmed by Sanger
Total2033  
Trisomy 212222/22
Trisomy 1844/4
Trisomy 1311/1
SCA22/2
Microdeletion syndromes55/5
Number of samples with no mutations1497 496/496a
Number of samples with mutations536 
Number of mutations613 
Number of unique mutations87 87/87
  1. aAll 496 targeted mutations were confirmed in 5 randomly selected normal (wild-type) samples